Annexin A1
Diabetes
Inflammation
Protein Annexin A1
Skin lesion
Wound healing
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
16
05
2023
revised:
22
07
2023
accepted:
24
07
2023
medline:
17
8
2023
pubmed:
3
8
2023
entrez:
2
8
2023
Statut:
ppublish
Résumé
Diabetes mellitus (DM) is characterized by metabolic alterations that involve defects in the secretion and/or action of insulin, being responsible for several complications, such as impaired healing. Studies from our research group have shown that annexin A1 protein (AnxA1) is involved in the regulation of inflammation and cell proliferation. In light of these findings, we have developed a new technology and evaluated its effect on a wound healing in vivo model using type 1 diabetes (T1DM)-induced mice. We formulated a hydrogel containing AnxA1
Identifiants
pubmed: 37531784
pii: S0753-3322(23)01021-1
doi: 10.1016/j.biopha.2023.115230
pii:
doi:
Substances chimiques
Hydrogels
0
Annexin A1
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115230Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.